This led, eventually, to a technique for releasing the drug paclitaxel into selected blood - vessel tissue, slowing the arterial blockage that
causes peripheral artery disease.
Not exact matches
The clear result of this clinical study — that the combination reduced strokes, heart attacks and cardiovascular death by practically 25 per cent compared to either drug alone in both patients with stable coronary or
peripheral artery disease —
caused the clinical trial to be stopped early, after 23 months, in February 2017.
Atherosclerosis, the hardening and narrowing of
arteries, is the most common
cause of heart attacks, strokes and
peripheral vascular disease, conditions that are commonly summed up as cardiovascular disease.
While
peripheral artery disease (PAD) can make walking or any other type of exercise painful, exercise is actually one of the most beneficial things that you can do to reduce the pain
caused by PAD.
The depletion of blood volume due to low sodium
causes a phenomenon known as «total
peripheral resistance» meaning the
arteries become more constricted and the heart needs to pump harder.
A disease called
peripheral artery disease, or PAD,
causes blockages in your lower limbs preventing normal blood flow.
The inflammation makes cholesterol and other junk to stick to the walls of the
arteries which in turn
causes narrowing of the
arteries which in turn can
cause a heart attack, stroke, or
peripheral artery disease.
This can
cause heart disease, heart attack,
peripheral artery disease (reduced blood flow in the limbs, usually the legs), or stroke.